1. Home
  2. ESPR vs PBFS Comparison

ESPR vs PBFS Comparison

Compare ESPR & PBFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • PBFS
  • Stock Information
  • Founded
  • ESPR 2008
  • PBFS 1889
  • Country
  • ESPR United States
  • PBFS United States
  • Employees
  • ESPR N/A
  • PBFS N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • PBFS Banks
  • Sector
  • ESPR Health Care
  • PBFS Finance
  • Exchange
  • ESPR Nasdaq
  • PBFS Nasdaq
  • Market Cap
  • ESPR 305.0M
  • PBFS 309.6M
  • IPO Year
  • ESPR 2013
  • PBFS N/A
  • Fundamental
  • Price
  • ESPR $1.67
  • PBFS $11.87
  • Analyst Decision
  • ESPR Buy
  • PBFS
  • Analyst Count
  • ESPR 7
  • PBFS 0
  • Target Price
  • ESPR $6.36
  • PBFS N/A
  • AVG Volume (30 Days)
  • ESPR 4.2M
  • PBFS 26.6K
  • Earning Date
  • ESPR 03-04-2025
  • PBFS 05-12-2025
  • Dividend Yield
  • ESPR N/A
  • PBFS N/A
  • EPS Growth
  • ESPR N/A
  • PBFS 11.77
  • EPS
  • ESPR N/A
  • PBFS 0.76
  • Revenue
  • ESPR $332,314,000.00
  • PBFS $88,118,000.00
  • Revenue This Year
  • ESPR $5.51
  • PBFS N/A
  • Revenue Next Year
  • ESPR $1.42
  • PBFS N/A
  • P/E Ratio
  • ESPR N/A
  • PBFS $15.61
  • Revenue Growth
  • ESPR 185.66
  • PBFS 21.67
  • 52 Week Low
  • ESPR $1.47
  • PBFS $8.76
  • 52 Week High
  • ESPR $3.94
  • PBFS $12.20
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 45.39
  • PBFS 48.49
  • Support Level
  • ESPR $1.47
  • PBFS $11.77
  • Resistance Level
  • ESPR $1.69
  • PBFS $12.04
  • Average True Range (ATR)
  • ESPR 0.12
  • PBFS 0.23
  • MACD
  • ESPR 0.02
  • PBFS -0.02
  • Stochastic Oscillator
  • ESPR 39.74
  • PBFS 30.51

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About PBFS Pioneer Bancorp Inc.

Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.

Share on Social Networks: